These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 29606398)
21. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type. Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U; Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483 [TBL] [Abstract][Full Text] [Related]
22. Tissue factor expression in neutrophil extracellular traps and neutrophil derived microparticles in antineutrophil cytoplasmic antibody associated vasculitis may promote thromboinflammation and the thrombophilic state associated with the disease. Kambas K; Chrysanthopoulou A; Vassilopoulos D; Apostolidou E; Skendros P; Girod A; Arelaki S; Froudarakis M; Nakopoulou L; Giatromanolaki A; Sidiropoulos P; Koffa M; Boumpas DT; Ritis K; Mitroulis I Ann Rheum Dis; 2014 Oct; 73(10):1854-63. PubMed ID: 23873874 [TBL] [Abstract][Full Text] [Related]
23. Neutrophils from vasculitis patients exhibit an increased propensity for activation by anti-neutrophil cytoplasmic antibodies. Ohlsson SM; Ohlsson S; Söderberg D; Gunnarsson L; Pettersson Å; Segelmark M; Hellmark T Clin Exp Immunol; 2014 Jun; 176(3):363-72. PubMed ID: 24666336 [TBL] [Abstract][Full Text] [Related]
24. CD14 expression is increased on monocytes in patients with anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis and correlates with the expression of ANCA autoantigens. Tarzi RM; Liu J; Schneiter S; Hill NR; Page TH; Cook HT; Pusey CD; Woollard KJ Clin Exp Immunol; 2015 Jul; 181(1):65-75. PubMed ID: 25766482 [TBL] [Abstract][Full Text] [Related]
25. Neutrophil extracellular traps in neuropathy with anti-neutrophil cytoplasmic autoantibody-associated microscopic polyangiitis. Takeuchi H; Kawasaki T; Shigematsu K; Kawamura K; Oka N Clin Rheumatol; 2017 Apr; 36(4):913-917. PubMed ID: 28124760 [TBL] [Abstract][Full Text] [Related]
26. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China. Chang DY; Li ZY; Chen M; Zhao MH Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327 [TBL] [Abstract][Full Text] [Related]
27. Protective effect of astaxanthin on ANCA-associated vasculitis. Sun RL; Shang JC; Han RH; Xing GQ Int Immunopharmacol; 2024 May; 132():111928. PubMed ID: 38537540 [TBL] [Abstract][Full Text] [Related]
28. An Autopsy Case of Myeloperoxidase-anti-neutrophil Cytoplasmic Antibody (MPO-ANCA)-associated Vasculitis Accompanied by Cryoglobulinemic Vasculitis Affecting the Kidneys, Skin, and Gastrointestinal Tract. Hasegawa J; Wakai S; Kono M; Imaizumi Y; Masuda S; Ishizu A; Honda K Intern Med; 2018 Sep; 57(18):2739-2745. PubMed ID: 29709950 [TBL] [Abstract][Full Text] [Related]
29. Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial. Sanders JS; de Joode AA; DeSevaux RG; Broekroelofs J; Voskuyl AE; van Paassen P; Kallenberg CG; Tervaert JW; Stegeman CA Nephrol Dial Transplant; 2016 Sep; 31(9):1453-9. PubMed ID: 27242368 [TBL] [Abstract][Full Text] [Related]
31. Incidence of PR3- and MPO-ANCA autoantibody specificity changes in ANCA-associated vasculitis. Holding S; Fisher VJ; Abuzakouk M Ann Clin Biochem; 2015 Mar; 52(Pt 2):297-301. PubMed ID: 24723621 [TBL] [Abstract][Full Text] [Related]
32. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Sangaletti S; Tripodo C; Chiodoni C; Guarnotta C; Cappetti B; Casalini P; Piconese S; Parenza M; Guiducci C; Vitali C; Colombo MP Blood; 2012 Oct; 120(15):3007-18. PubMed ID: 22932797 [TBL] [Abstract][Full Text] [Related]
33. Association Between Reappearance of Myeloperoxidase-Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Subgroup Analysis of Nationwide Prospective Cohort Studies. Watanabe H; Sada KE; Matsumoto Y; Harigai M; Amano K; Dobashi H; Fujimoto S; Usui J; Yamagata K; Atsumi T; Banno S; Sugihara T; Arimura Y; Matsuo S; Makino H; Arthritis Rheumatol; 2018 Oct; 70(10):1626-1633. PubMed ID: 29790303 [TBL] [Abstract][Full Text] [Related]
34. IgA- and SIgA anti-PR3 antibodies in serum versus organ involvement and disease activity in PR3-ANCA-associated vasculitis. Sandin C; Eriksson P; Segelmark M; Skogh T; Kastbom A Clin Exp Immunol; 2016 May; 184(2):208-15. PubMed ID: 26762653 [TBL] [Abstract][Full Text] [Related]
35. Impact of anti-glomerular basement membrane antibodies and glomerular neutrophil activation on glomerulonephritis in experimental myeloperoxidase-antineutrophil cytoplasmic antibody vasculitis. Kanzaki G; Nagasaka S; Higo S; Kajimoto Y; Kanemitsu T; Aoki M; Nagahama K; Natori Y; Tsuboi N; Yokoo T; Shimizu A Nephrol Dial Transplant; 2016 Apr; 31(4):574-85. PubMed ID: 26582929 [TBL] [Abstract][Full Text] [Related]
36. CD47 blockade ameliorates autoimmune vasculitis via efferocytosis of neutrophil extracellular traps. Shiratori-Aso S; Nakazawa D; Kudo T; Kanda M; Ueda Y; Watanabe-Kusunoki K; Nishio S; Iwasaki S; Tsuji T; Masuda S; Tomaru U; Ishizu A; Atsumi T JCI Insight; 2023 Aug; 8(15):. PubMed ID: 37368493 [TBL] [Abstract][Full Text] [Related]
37. High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation. Ma YH; Ma TT; Wang C; Wang H; Chang DY; Chen M; Zhao MH Arthritis Res Ther; 2016 Jan; 18():2. PubMed ID: 26739852 [TBL] [Abstract][Full Text] [Related]
38. [The clinical significance of circulating follicular helper T cells in patients with anti-neutrophil cytoplasmic myeloperoxidase antibody-associated vasculitis]. Wang S; Zheng MJ; Zhou XL; Liu YQ; Shuai ZW Zhonghua Nei Ke Za Zhi; 2018 Oct; 57(10):738-742. PubMed ID: 30293334 [No Abstract] [Full Text] [Related]
39. Clinical features and treatment outcomes of otitis media with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (OMAAV): A retrospective analysis of 235 patients from a nationwide survey in Japan. Harabuchi Y; Kishibe K; Tateyama K; Morita Y; Yoshida N; Kunimoto Y; Matsui T; Sakaguchi H; Okada M; Watanabe T; Inagaki A; Kobayashi S; Iino Y; Murakami S; Takahashi H; Tono T Mod Rheumatol; 2017 Jan; 27(1):87-94. PubMed ID: 27166750 [TBL] [Abstract][Full Text] [Related]
40. IgM ANCA in healthy individuals and in patients with ANCA-associated vasculitis. Jeffs LS; Peh CA; Nelson A; Tan PG; Davey E; Chappell K; Perkins GB; Hurtado PR Immunol Res; 2019 Oct; 67(4-5):325-336. PubMed ID: 31372816 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]